Amoxin Uses

Rating: 5 - 1 review(s)
sponsored

What is Amoxin?

Amoxin is a penicillin antibiotic that fights bacteria.

Amoxin is used to treat many different types of infection caused by bacteria, such as tonsillitis, bronchitis, pneumonia, gonorrhea, and infections of the ear, nose, throat, skin, or urinary tract.

Amoxin is also sometimes used together with another antibiotic called clarithromycin (Biaxin) to treat stomach ulcers caused by Helicobacter pylori infection. This combination is sometimes used with a stomach acid reducer called lansoprazole (Prevacid).

There are many brands and forms of Amoxin available and not all brands are listed on this leaflet.

Amoxin may also be used for purposes not listed in this medication guide.

Amoxin indications

infoAn indication is a term used for the list of condition or symptom or illness for which the medicine is prescribed or used by the patient. For example, acetaminophen or paracetamol is used for fever by the patient, or the doctor prescribes it for a headache or body pains. Now fever, headache and body pains are the indications of paracetamol. A patient should be aware of the indications of medications used for common conditions because they can be taken over the counter in the pharmacy meaning without prescription by the Physician.
sponsored

Infections of the Ear, Nose, and Throat

Amoxin Capsules, Amoxin for oral suspension, Amoxin tablets (chewable) are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Streptococcus species (α- and β-hemolytic isolates only), Streptococcus pneumoniae, Staphylococcus spp., or Haemophilus influenzae.

Infections of the Genitourinary Tract

Amoxin Capsules, Amoxin for oral suspension, Amoxin tablets (chewable) are indicated in the treatment of infections due to susceptible (ONLY β-lactamase–negative) isolates of Escherichia coli, Proteus mirabilis, or Enterococcus faecalis.

Infections of the Skin and Skin Structure

Amoxin Capsules, Amoxin for oral suspension, Amoxin tablets (chewable) are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus spp. (α- and β-hemolytic isolates only), Staphylococcus spp., or E. coli.

Infections of the Lower Respiratory Tract

Amoxin Capsules, Amoxin for oral suspension, Amoxin tablets (chewable) are indicated in the treatment of infections due to susceptible (ONLY β-lactamase-negative) isolates of Streptococcus spp. (α- and β-hemolytic isolates only), S. pneumoniae, Staphylococcus spp., or H. influenzae.

Helicobacter pylori Infection

Triple therapy for Helicobacter pylori with clarithromycin and lansoprazole:

Amoxin, in combination with clarithromycin plus lansoprazole as triple therapy, is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1 year history of a duodenal ulcer) to eradicate H. pylori. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.

Dual therapy for H. pylori with lansoprazole:

Amoxin, in combination with lansoprazole delayed-release capsules as dual therapy, is indicated for the treatment of patients with H. pylori infection and duodenal ulcer disease (active or 1 year history of a duodenal ulcer) who are either allergic or intolerant to clarithromycin or in whom resistance to clarithromycin is known or suspected. Eradication of H. pylori has been shown to reduce the risk of duodenal ulcer recurrence.

Usage

To reduce the development of drug-resistant bacteria and maintain the effectiveness of Amoxin and other antibacterial drugs, Amoxin should be used only to treat infections that are proven or strongly suspected to be caused by bacteria. When culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. In the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy.

How should I use Amoxin?

Use Amoxin as directed by your doctor. Check the label on the medicine for exact dosing instructions.

  • Take Amoxin by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.
  • Shake well before each use.
  • Use a measuring device marked for medicine dosing. Ask your pharmacist for help if you are unsure of how to measure your dose.
  • Amoxin may be mixed with formula, milk, fruit juice, water, ginger ale, or other cold drinks. If you mix Amoxin, take it at once after mixing. Be sure that the entire dose is swallowed.
  • To clear up your infection completely, take Amoxin for the full course of treatment. Keep taking it even if you feel better in a few days.
  • If you miss a dose of Amoxin, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Amoxin.

Uses of Amoxin in details

infoThere are specific as well as general uses of a drug or medicine. A medicine can be used to prevent a disease, treat a disease over a period or cure a disease. It can also be used to treat the particular symptom of the disease. The drug use depends on the form the patient takes it. It may be more useful in injection form or sometimes in tablet form. The drug can be used for a single troubling symptom or a life-threatening condition. While some medications can be stopped after few days, some drugs need to be continued for prolonged period to get the benefit from it.
sponsored

Amoxin belongs to a class of antibiotic medicines called penicillin. It is used to treat bacterial infections of the respiratory tract (bronchitis, pneumonia), genital and urinary tract (gonorrhoea, ), skin and soft tissue, ear (otitis media); nose, sinus, and throat (tonsillitis, sinusitis); heart (endocarditis), kidney, urethra or bladder, blood (septicemia), teeth and gums (abcesses), typhoid and paratyphoid fever.

Amoxin description

A broad-spectrum semisynthetic antibiotic similar to ampicillin except that its resistance to gastric acid permits higher serum levels with oral administration. Amoxin is commonly prescribed with clauvanic acid (a beta lactamase inhibitor) as it is susceptible to beta-lacatamase degradation. [PubChem]

Amoxin dosage

Amoxin may be given without regard to meals.

Direction for Amoxin Tablets for

Oral Suspension

Mix one tablet in a small amount of water [approximately 2 teaspoonfuls]. Drink the entire mixture. Rinse the container with an additional small amount of water and drink the contents to assure the whole dose is taken. Do not chew or swallow the tablets. The tablets will not rapidly dissolve in your mouth.

The tablet is not recommended to be mixed with any liquid other than water, as studies have only been conducted using water.

ALL RECOMMENDED DOSAGES FOR Amoxin ARE INCLUDED IN THIS SECTION FOR INFORMATIONAL PURPOSES ONLY. THE 200 mg TABLET FOR ORAL SUSPENSION IS APPROPRIATE ONLY FOR A 200 mg DOSE AND THE 400 mg TABLET FOR ORAL SUSPENSION IS APPROPRIATE ONLY FOR A 400 mg DOSE.

Neonates and infants aged ≤ 12 weeks (≤ 3 months)

Due to incompletely developed renal function affecting elimination of Amoxin in this age group, the recommended upper dose of Amoxin is 30 mg/kg/day divided q12h.

Adults and pediatric patients > 3 months

All patients with gonorrhea should be evaluated for syphilis.

Larger doses may be required for stubborn or severe infections.

General

It should be recognized that in the treatment of chronic urinary tract infections, frequent bacteriological and clinical appraisals are necessary. Smaller doses than those recommended above should not be used. Even higher doses may be needed at times. In stubborn infections, therapy may be required for several weeks. It may be necessary to continue clinical and/or bacteriological follow-up for several months after cessation of therapy. Except for gonorrhea, treatment should be continued for a minimum of 48 to 72 hours beyond the time that the patient becomes asymptomatic or evidence of bacterial eradication has been obtained. It is recommended that there be at least 10 days’ treatment for any infection caused by Streptococcus pyogenes to prevent the occurrence of acute rheumatic fever. H. pylori eradication to reduce the risk of duodenal ulcer recurrence

Triple therapy: Amoxicillin/clarithromycin/lansoprazole

The recommended adult oral dose is 1 gram Amoxin, 500 mg clarithromycin, and 30 mg lansoprazole, all given twice daily (q12h) for 14 days.

Dual therapy: Amoxicillin/lansoprazole

The recommended adult oral dose is 1 gram Amoxin and 30 mg lansoprazole, each given three times daily (q8h) for 14 days.

Please refer to clarithromycin and lansoprazole full prescribing information for and, and for information regarding dosing in elderly and renally impaired patients.

Dosing recommendations for adults with impaired renal function:

Patients with impaired renal function do not generally require a reduction in dose unless the impairment is severe. Severely impaired patients with a glomerular filtration rate of < 30 mL/minute should not receive the 875 mg tablet. Patients with a glomerular filtration rate of 10 to 30 mL/minute should receive 500 mg or 250 mg every 12 hours, depending on the severity of the infection. Patients with a less than 10 mL/minute glomerular filtration rate should receive 500 mg or 250 mg every 24 hours, depending on severity of the infection.

Hemodialysis patients should receive 500 mg or 250 mg every 24 hours, depending on severity of the infection. They should receive an additional dose both during and at the end of dialysis.

There are currently no dosing recommendations for pediatric patients with impaired renal function.

Amoxin interactions

sponsored

Amoxin may decrease the effectiveness of contraceptives for oral administration.

With the simultaneous use of Amoxin Lafayette Pharmaceutical Laboratory with bactericidal antibiotics (including aminoglycosides, cephalosporins, cycloserine, vancomycin, rifampicin) appears synergies; with bacteriostatic antibiotic (including macrolides, chloramphenicol, lincosamides, tetracyclines, sulphonamide) - antagonism.

Amoxin increases the effects of indirect anticoagulants inhibiting intestinal microflora, reduces the synthesis of vitamin K and prothrombin index.

Amoxin reduces the effect of drugs, in the process of metabolism that produce PABA.

Probenecid, diuretics, allopurinol, phenylbutazone, NSAIDs decrease the tubular secretion of Amoxin, which can be accompanied by an increase in its concentration in blood plasma.

Antacids, glucosamine, laxatives, aminoglycosides, slow down and reduce, and ascorbic acid increases the absorption of Amoxin.

With the combined use of Amoxin and clavulanic acid pharmacokinetics of both components unchanged.

Amoxin side effects

sponsored

As with other penicillins, it may be expected that untoward reactions will be essentially limited to sensitivity phenomena. They are more likely to occur in individuals who have previously demonstrated hypersensitivity to penicillins and in those with a history of allergy, asthma, hay fever, or urticaria. The following adverse reactions have been reported as associated with the use of penicillins:

Gastrointestinal: nausea, vomiting, diarrhea, and hemorrhagic/pseudomembranous colitis.

Onset of pseudomembranous colitis symptoms may occur during or after antibiotic treatment.

Hypersensitivity Reactions: Serum sickness like reactions, erythematous maculopapular rashes, erythema multiforme, Stevens-Johnson syndrome, exfoliative dermatitis, toxic epidermal necrolysis, acute generalized exanthematous pustulosis, hypersensitivity vasculitis and urticaria have been reported.

NOTE: These hypersensitivity reactions may be controlled with antihistamines and, if necessary, systemic corticosteroids. Whenever such reactions occur, Amoxin should be discontinued unless, in the opinion of the physician, the condition being treated is life-threatening and amenable only to Amoxin therapy.

Liver: A moderate rise in AST (SGOT) and/or ALT (SGPT) has been noted, but the significance of this finding is unknown. Hepatic dysfunction including cholestatic jaundice, hepatic cholestasis, and acute cytolytic hepatitis have been reported.

Renal: Crystalluria has also been reported.

Hemic and Lymphatic Systems: Anemia, including hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, and agranulocytosis have been reported during therapy with penicillins. These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena.

Central Nervous System: Reversible hyperactivity, agitation, anxiety, insomnia, confusion, convulsions, behavioral changes, and/or dizziness have been reported rarely.

Miscellaneous: Tooth discoloration (brown, yellow, or gray staining) has been rarely reported. Most reports occurred in pediatric patients. Discoloration was reduced or eliminated with brushing or dental cleaning in most cases.

Combination therapy with clarithromycin and lansoprazole

In clinical trials using combination therapy with Amoxin plus clarithromycin and lansoprazole, and Amoxin plus lansoprazole, no adverse reactions peculiar to these drug combinations were observed. Adverse reactions that have occurred have been limited to those that had been previously reported with Amoxin, clarithromycin, or lansoprazole.

Triple therapy: amoxicillin/clarithromycin/lansoprazole

The most frequently reported adverse events for patients who received triple therapy were diarrhea (7%), headache (6%), and taste perversion (5%). No treatment-emergent adverse events were observed at significantly higher rates with triple therapy than with any dual therapy regimen.

Dual therapy: amoxicillin/lansoprazole

The most frequently reported adverse events for patients who received Amoxin t.i.d. plus lansoprazole t.i.d. dual therapy were diarrhea (8%) and headache (7%). No treatment-emergent adverse events were observed at significantly higher rates with Amoxin t.i.d. plus lansoprazole t.i.d. dual therapy than with lansoprazole alone.

For more information on adverse reactions with clarithromycin or lansoprazole, refer to their package inserts, ADVERSE REACTIONS.

Amoxin contraindications

Infectious mononucleosis, lymphatic leukemia, severe gastrointestinal infections, accompanied by diarrhea or vomiting, respiratory viral infection, allergic diathesis, bronchial asthma, hay fever, sensitivity to penicillin and / or cephalosporins.

For use in combination with metronidazole: diseases of the nervous system; hemodyscrasia, lymphocytic leukemia, an infectious mononucleosis; Hypersensitivity to nitroimidazole derivatives.

For use in combination with clavulanic acid: a history of instructions for liver problems and jaundice, associated with the reception of Amoxin in combination with clavulanic acid.

Amoxin pregnancy

Amoxin has been assigned to pregnancy category B by the FDA. Animal studies using 10 times the human dose have failed to reveal any evidence of teratogenicity. Although no controlled data in human pregnancy are available, literature reports of adverse fetal effects are lacking. Amoxin is only recommended during pregnancy when benefit outweighs risk.

In the Collaborative Perinatal Project involving 50,282 mother-child pairs, there were 3,546 mother-child pairs exposed to penicillin derivatives in the first trimester. As a group, there was no significant increase in the risk of malformations. In the Michigan Medicaid Birth Defects Study involving 229,101 pregnancies from 1985 to 1992, there were 8,538 first trimester exposures to Amoxin. Overall, 317 cases of birth defects were observed (363 expected). There was no evidence of an association between first trimester use of Amoxin and major groups of malformations. A Danish study of 401 women exposed to Amoxin during pregnancy from 1991 to 2000 did not find an increased risk of birth defects or adverse outcomes compared to women who had taken no medication. Transient decreases in total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol plasma concentrations have been reported in pregnant women who received ampicillin and this may also occur with Amoxin.

Amoxin overdose

).

Hemic and Lymphatic Systems: Anemia, including hemolytic anemia, thrombocytopenia, thrombocytopenic purpura, eosinophilia, leukopenia, and agranulocytosis have been reported during therapy with penicillins. These reactions are usually reversible on discontinuation of therapy and are believed to be hypersensitivity phenomena.

Central Nervous System: Reversible hyperactivity, agitation, anxiety, insomnia, confusion, convulsions, behavioral changes, and/or dizziness have been reported rarely.

Miscellaneous: Tooth discoloration (brown, yellow, or gray staining) has been rarely reported. Most reports occurred in pediatric patients. Discoloration was reduced or eliminated with brushing or dental cleaning in most cases.

Combination Therapy With Clarithromycin and Lansoprazole

In clinical trials using combination therapy with Amoxin plus clarithromycin and lansoprazole, and Amoxin plus lansoprazole, no adverse reactions peculiar to these drug combinations were observed. Adverse reactions that have occurred have been limited to those that had been previously reported with Amoxin, clarithromycin, or lansoprazole.

Triple Therapy

Amoxicillin/clarithromycin/lansoprazole

The most frequently reported adverse events for patients who received triple therapy were diarrhea (7%), headache (6%), and taste perversion (5%). No treatment-emergent adverse events were observed at significantly higher rates with triple therapy than with any dual therapy regimen.

Dual Therapy

Amoxicillin/lansoprazole

The most frequently reported adverse events for patients who received Amoxin three times daily plus lansoprazole three times daily dual therapy were diarrhea (8%) and headache (7%). No treatment-emergent adverse events were observed at significantly higher rates with Amoxin three times daily plus lansoprazole three times daily dual therapy than with lansoprazole alone.

For more information on adverse reactions with clarithromycin or lansoprazole, refer to their package inserts,

Amoxin precautions

General

Prescribing Amoxin tablets for oral suspension in the absence of a proven or strongly suspected bacterial infection or a prophylactic indication is unlikely to provide benefit to the patient and increases the risk of the development of drug-resistant bacteria.

The possibility of superinfections with mycotic or bacterial pathogens should be kept in mind during therapy. If superinfections occur, Amoxin should be discontinued and appropriate therapy instituted.

Information for Patients

Patients should be counseled that antibacterial drugs including Amoxin tablets for oral suspension should only be used to treat bacterial infections. They do not treat viral infections (e.g., the common cold). When Amoxin tablets for oral suspension are prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy the medicine should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelihood that bacteria will develop resistance and will not be treatable by Amoxin tablets for oral suspension or other antibacterial drugs in the future.

A Patient Information Sheet is provided with the drug product.

Phenylketonurics

Each 200 mg Amoxin tablet for oral suspension contains 3.1 mg phenylalanine; each 400 mg Amoxin tablet for oral suspension contains 6.2 mg phenylalanine.

Laboratory Tests

As with any potent drug, periodic assessment of renal, hepatic, and hematopoietic function should be made during prolonged therapy.

All patients with gonorrhea should have a serologic test for syphilis at the time of diagnosis. Patients treated with Amoxin should have a follow-up serologic test for syphilis after 3 months.

Drug Interactions

Probenecid decreases the renal tubular secretion of Amoxin. Concurrent use of Amoxin and probenecid may result in increased and prolonged blood levels of Amoxin.

Chloramphenicol, macrolides, sulfonamides, and tetracyclines may interfere with the bactericidal effects of penicillin. This has been demonstrated in vitro; however, the clinical significance of this interaction is not well documented.

Drug/Laboratory Test Interactions

High urine concentrations of ampicillin may result in false-positive reactions when testing for the presence of glucose in urine using Clinitest®, Benedict’s Solution or Fehling’s Solution. Since this effect may also occur with Amoxin, it is recommended that glucose tests based on enzymatic glucose oxidase reactions (such as Clinistix®) be used.

Following administration of ampicillin to pregnant women, a transient decrease in plasma concentration of total conjugated estriol, estriol-glucuronide, conjugated estrone, and estradiol has been noted. This effect may also occur with Amoxin.

Carcinogenesis, Mutagenesis, Impairment of Fertility

Long-term studies in animals have not been performed to evaluate carcinogenic potential. Studies to detect mutagenic potential of Amoxin alone have not been conducted; however, the following information is available from tests on a 4:1 mixture of Amoxin and potassium clavulanate. Mixture of Amoxin and potassium clavulanate was non-mutagenic in the Ames bacterial mutation assay, and the yeast gene conversion assay. Mixture of Amoxin and potassium clavulanate was weakly positive in the mouse lymphoma assay, but the trend toward increased mutation frequencies in this assay occurred at doses that were also associated with decreased cell survival. Mixture of Amoxin and potassium clavulanate was negative in the mouse micronucleus test, and in the dominant lethal assay in mice. Potassium clavulanate alone was tested in the Ames bacterial mutation assay and in the mouse micro-nucleus test, and was negative in each of these assays. In a multi-generation reproduction study in rats, no impairment of fertility or other adverse reproductive effects were seen at doses up to 500 mg/kg (approximately 3 times the human dose in mg/m2).

Pregnancy

Teratogenic Effects

Pregnancy Category B.

Reproduction studies have been performed in mice and rats at doses up to ten (10) times the human dose and have revealed no evidence of impaired fertility or harm to the fetus due to Amoxin. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, this drug should be used during pregnancy only if clearly needed.

Labor and Delivery

Oral ampicillin-class antibiotics are poorly absorbed during labor. Studies in guinea pigs showed that intravenous administration of ampicillin slightly decreased the uterine tone and frequency of contractions but moderately increased the height and duration of contractions. However, it is not known whether use of Amoxin in humans during labor or delivery has immediate or delayed adverse effects on the fetus, prolongs the duration of labor, or increases the likelihood that forceps delivery or other obstetrical intervention or resuscitation of the newborn will be necessary.

Nursing Mothers

Penicillins have been shown to be excreted in human milk. Amoxin use by nursing mothers may lead to sensitization of infants. Caution should be exercised when Amoxin is administered to a nursing woman.

Pediatric Use

Because of incompletely developed renal function in neonates and young infants, the elimination of Amoxin may be delayed. Dosing of Amoxin should be modified in pediatric patients 12 weeks or younger (≤ 3 months).

Geriatric Use

An analysis of clinical studies of Amoxin was conducted to determine whether subjects aged 65 and over respond differently from younger subjects. Of the 1,811 subjects treated with capsules of Amoxin, 85% were <60 years old, 15% were ≥61 years old and 7% were ≥71 years old. This analysis and other reported clinical experience have not identified differences in responses between the elderly and younger patients, but a greater sensitivity of some older individuals cannot be ruled out. This drug is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.



Active ingredient matches for Amoxin:

Amoxicillin in Ethiopia, Finland, Germany, Kenya.

Amoxicillin trihydrate in Finland.

Amoxycillin trihydrate in Thailand.


Unit description / dosage (Manufacturer)Price, USD
Amoxin 250 mg x 500's
Amoxin 250 mg x 1, 000's
Amoxin 500 mg x 500's
Amoxin 500 mg x 1, 000's
Amoxin 125 mg/5 mL x 60 mL

List of Amoxin substitutes (brand and generic names):

Tablet, Film-Coated; Oral; Amoxicillin Trihydrate 750 mg (Cimex)
AMOXINGA Capsule/ Tablet / 500mg / 6 units (Inga)$ 0.59
AMOXINGA Liquid / 125mg per 5ml / 60ml units (Inga)$ 0.44
AMOXINGA Capsule/ Tablet / 250mg / 6 units (Inga)$ 0.34
AMOXINGA Capsule/ Tablet / 125mg / 10 units (Inga)$ 0.34
AMOXINGA Dispersible Tablet / 250mg / 15 units (Inga)$ 0.90
Amoxinga 250mg CAP / 6 (Inga)$ 0.36
Amoxinga 500mg CAP / 6 (Inga)$ 0.59
Amoxinga 125mg P-TAB / 10 (Inga)$ 0.34
Amoxinga 250mg DT-TAB / 15 (Inga)$ 0.90
250 mg x 6's (Inga)$ 0.36
500 mg x 6's (Inga)$ 0.59
125 mg x 10's (Inga)$ 0.34
250 mg x 15's (Inga)$ 0.90
AMOXINGA cap 250 mg x 6's (Inga)$ 0.36
AMOXINGA cap 500 mg x 6's (Inga)$ 0.59
AMOXINGA P- tab 125 mg x 10's (Inga)$ 0.34
AMOXINGA dispertab 250 mg x 15's (Inga)$ 0.90
Amoxinga SYR 125mg SYR / 60ml (Inga)$ 0.44
125 mg x 60ml (Inga)$ 0.44
AMOXINGA SYR syr 125 mg x 60ml (Inga)$ 0.44
Capsule; Oral; Amoxicillin Trihydrate 250 mg (Novag)
Capsule; Oral; Amoxicillin Trihydrate 500 mg (Novag)
Suspension; Oral; Amoxicillin Trihydrate 250 mg / 5 ml (Novag)
Suspension; Oral; Amoxicillin Trihydrate 500 mg / 5 ml (Novag)
AMOXIPEN Capsule/ Tablet / 250mg / 10 units (PCI)$ 0.62
AMOXIPEN Liquid / 125mg per 5ml / 60ml units (PCI)$ 0.52
AMOXIPEN Capsule/ Tablet / 500mg / 10 units (PCI)$ 1.16
AMOXIPEN Liquid / 250mg per 5ml / 30ml units (PCI)$ 0.45
AMOXIPEN Liquid / 125mg per 5ml / 30ml units (PCI)$ 0.28
Amoxipen 250mg CAP / 10 (PCI)$ 0.62
Amoxipen 500mg CAP / 10 (PCI)$ 1.16
Amoxipen 125mgx5mL SYR / 30ml (PCI)$ 0.28
Amoxipen 125mgx5mL SYR / 60ml (PCI)$ 0.52

References

  1. DailyMed. "AMOXICILLIN; CLAVULANATE POTASSIUM: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
  2. PubChem. "amoxicillin". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
  3. DrugBank. "amoxicillin". http://www.drugbank.ca/drugs/DB01060 (accessed September 17, 2018).
  4. Wikipedia. "amoxicillin anhydrous: Link to the compound information in Wikipedia.". https://en.wikipedia.org/wiki/Amoxic... (accessed September 17, 2018).
  5. MeSH. "Anti-Bacterial Agents". https://www.ncbi.nlm.nih.gov/mesh/68... (accessed September 17, 2018).

Reviews

The results of a survey conducted on ndrugs.com for Amoxin are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Amoxin. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.

User reports

1 consumer reported useful

Was the Amoxin drug useful in terms of decreasing the symptom or the disease?
According to the reports released by ndrugs.com website users, the below mentioned percentages of users say the drug is useful / not useful to them in decreasing their symptoms/disease. The usefulness of the drug depends on many factors, like severity of the disease, perception of symptom, or disease by the patient, brand name used [matters only to a certain extent], other associated conditions of the patient. If the drug is not effective or useful in your case, you need to meet the doctor to get re-evaluated about your symptoms/disease, and he will prescribe an alternative drug.
Users%
Useful1
100.0%

1 consumer reported price estimates

Was the price you paid to purchase the drug reasonable? Did you feel it was expensive?
The below mentioned numbers have been reported by ndrugs.com website users about whether the Amoxin drug is expensive or inexpensive. There is a mixed opinion among users. The rating about the cost of the drug depends on factors like which brand drug the patient purchased, how effective it was for the price paid, the country or place the drug is marketed, and the economic condition of the patient. The users who feel the drug is expensive can look for an alternative brand drug or a generic drug to save the cost.
Users%
Expensive1
100.0%

2 consumers reported age

Users%
> 601
50.0%
30-451
50.0%

Consumer reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 20 here

Information checked by Dr. Sachin Kumar, MD Pharmacology

| Privacy Policy
This site does not supply any medicines. It contains prices for information purposes only.
© 2003 - 2018 ndrugs.com All Rights Reserved